Found: 1
Select item for more details and to access through your institution.
An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 9, p. 2199, doi. 10.1210/clinem/dgae121
- By:
- Publication type:
- Article